Cardlytics raises Q1 2023 guidance: revenue $63.5-66.5M, Adj EBITDA loss narrows to $5-8M

Cardlytics, Inc.

2023-Q1 EPS reported $0.40 revenue$64,331,000

Billings guidance raised to $93-97M from $84-93M; revenue to $63.5-66.5M from $54-63M.
Adjusted contribution guidance improved to $30-33M from $26-31M.
Adjusted EBITDA loss guidance narrowed to $5-8M from $10-17M, better than expected.
CEO Karim Temsamani cites product-led shift and $3.5M one-time cost savings as drivers.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cardlytics, Inc. reported the quarter ended March 31, 2023 results: revenue $63.5 - $66.5. Guidance raised.

Period: the quarter ended March 31, 2023
Revenue: $63.5 - $66.5
Guidance: raised
Result: guidance update

Exact text from the filing

EBITDA to be in the following ranges (in millions): Q1 2023 Previously Reported Guidance Q1 2023 Updated Guidance Billings $84.0 - $93.0 $93.0 - $97.0 Revenue $54.0 - $63.0 $63.5 - $66.5 Adjusted contribution $26.0 - $31.0 $30.0 - $33.0 Adjusted EBITDA ($17.0) - ($10.0) ($8.0) - ($5.0) "Despite a difficult macroeconomic environment, our shift to a

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-23-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.